A successful healthcare transaction starts with understanding how a business, product or technology will be assessed by potential buyers and partners. Gaps in evidence, positioning or preparation can delay discussions and weaken negotiating strength.
Sage Healthcare’s Deal Readiness Reviews help clients assess transaction potential, identify preparation gaps and establish a clear route to licensing, partnering or sale.
We consider the commercial opportunity alongside the supporting scientific, operational and financial information to help clients prepare a credible proposition.

From strategic assessment to full transaction execution
Is your company deal-ready?
For life-science companies facing a difficult funding and dealmaking environment, the question is not simply whether an asset has potential. The more important question is whether it is genuinely ready to attract a partner, licensee, investor or acquirer.
Based on 30+ years of dealmaking in the biopharma industry and very deep analytics using our SAGEIQ platform, Sage can rapidly assess whether a strategic transaction is credible now, identify the most relevant counterparties and define the most effective path from readiness to execution.
Sage Healthcare’s Deal Readiness Service helps life-science companies determine whether a licensing, partnering, M&A or strategic financing transaction is achievable — and what must be done to improve the probability of success.
Strong assets do not automatically produce successful transactions. Companies may have good science but still face:
unclear transaction positioning;
incomplete clinical, regulatory or IP narratives;
uncertain valuation expectations;
poorly prioritised partner lists;
previous outreach that has stalled;
limited cash runway; or
disagreement among management, boards and investors over the best strategic route.
The Deal Readiness Process is a focused entry programme designed to convert uncertainty into a clear transaction decision and a practical route to market.
For a detailed information document on this process, please click here!
The process begins with a focused, fixed-fee Deal Readiness Review, providing management and boards with a clear assessment of partnerability, strategic positioning, valuation metrics, transaction options, target counterparties and key gaps.
Where the opportunity is ready, Sage can then transition directly into a full strategic transaction mandate, leading global outreach, partner engagement, diligence, negotiation and transaction completion.






